Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Mar;75(3):388-95.
doi: 10.1136/jnnp.2003.017509.

A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA

Affiliations
Clinical Trial

A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA

J Marinus et al. J Neurol Neurosurg Psychiatry. 2004 Mar.

Abstract

Objectives: To evaluate the reliability and validity of the Short Parkinson's Evaluation Scale (SPES)/SCales for Outcomes in Parkinson's disease (SCOPA)-a short scale developed to assess motor function in patients with Parkinson's disease (PD).

Methods: Eighty five patients with PD were assessed with the SPES/SCOPA, Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn and Yahr (H&Y) scale, and Schwab and England (S&E) scale. Thirty four patients were examined twice by two different assessors who were blinded to each other's scores and test executions. Additionally, six items of the motor section of the SPES/SCOPA were assessed in nine patients and recorded on videotape to evaluate inter-rater and intra-rater reliability.

Results: The reproducibility of the sum scores in the clinical assessments was high for all subscales of the SPES/SCOPA. Inter-rater reliability coefficients for individual items ranged from 0.27-0.83 in the motor impairment section, from 0.58-0.82 in the activities of daily living section, and from 0.65-0.92 in the motor complications section. Inter-rater reliability of the motor items in the video assessments ranged from 0.70-0.87 and intra-rater reliability ranged from 0.81-0.95. The correlation between related subscales of the SPES/SCOPA and UPDRS were all higher than 0.85, and both scales revealed similar correlations with other measures of disease severity. The mean time to complete the scales differed significantly (p<0.001) and measured 8.1 (SD 1.9) minutes for the SPES/SCOPA and 15.6 (SD 3.6) minutes for the UPDRS.

Conclusion: The SPES/SCOPA is a short, reliable, and valid scale that can adequately be used in both research and clinical practice.

PubMed Disclaimer

References

    1. Nervenarzt. 2002 Aug;73(8):745-50 - PubMed
    1. Mov Disord. 2002 Jul;17(4):758-63 - PubMed
    1. Neurology. 1967 May;17(5):427-42 - PubMed
    1. Biometrics. 1977 Mar;33(1):159-74 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52 - PubMed

Publication types